|
|---|
Category:Memoranda
MONTHYEARML22353A5962023-07-0303 July 2023
Memorandum from Jlubinski to the Business Lines and Regions Re Implementation of Very Low Safety Significance Issue Resolution Process
ML23128A1222023-06-0101 June 2023
OEDO-23-00016 - Status of Recommendations: Audit of Coronavirus Disease'S Impact on Nuclear Materials and Waste Oversight (OIG-21-A-15)
ML23103A2032023-04-21021 April 2023
Cancellation of Inspection Programs Memoranda Regarding Implementation of Inspection Programs Following Re-Entry from the Public Health Emergency for the Nuclear Materials and Waste Safety Program
ML22334A2662022-12-0707 December 2022
OEDO-22-00453 - Status of Recommendations Audit of Coronavirus Disease'S Impact on Nuclear Materials and Waste Oversight (OIG-21-A-15)
ML22336A1762022-12-0707 December 2022
OEDO-22-00277 Status of Recommendations Office of the Inspector General'S Audit of the Nrc'S Process for Licensing Emerging Medical Technologies (OIG-22-A-07)
ML22140A1662022-05-25025 May 2022
Status of Recommendations for the Audit of the U.S. Nuclear Regulatory Commission Material Control and Accounting Inspection Program for Special Nuclear Material (OIG-21-A-04)
ML22095A2652022-04-18018 April 2022
OEDO-21-00468: Status of Recommendations Audit of Covid-19s Impact on Nuclear Materials and Waste Oversight OIG-21-15
ML22080A2182022-04-13013 April 2022
Cy 2021 Annual Report on Agreement States and U.S. NRCs Radioactive Materials Programs
ML22018A2242022-03-10010 March 2022
Responses to the ACMUI Recommendations on the Draft Alphadart Guidance
ML21361A0432022-01-26026 January 2022
Status Memo for OIG Audit of Nrc'S Use of RAIs in Licensing Processes for Snf, Audit Report OIG-21-A-08 - Ticket OEDO-21-00244-NMSS
ML21354A0152021-12-22022 December 2021
Memorandum from J. Lubinski Approval of Principal NMSS Tribal Liaison Program Roles and Responsibilities Tribal Procedure, TR-100, Revision. 1
ML21326A1722021-11-22022 November 2021
Draft Licensing Guidance for Superficial Manual Brachytherapy Civaderm Device for ACMUI Review
ML21294A2782021-11-0202 November 2021
Implementation of Inspection Programs Following Re-Entry from the Public Health Emergency Tor the Nuclear Materials and Waste Safety Program
ML21301A1602021-10-29029 October 2021
Memo - OIG-21-A-04 Status of Recommendations for the Audit of the NRC Mca Inspection Program for Special Nuclear Material
ML21153A1312021-06-21021 June 2021
OEDO-21-00127 - Update on Staff Response to the Office of Inspector General'S Audit of the U.S. Nuclear Regulatory Commission'S Emergency Preparedness Program (OIG-20-A-12)
ML21146A1152021-06-0909 June 2021
OEDO-20-00380 - OIG-20-A-15 NRC Response to Dr. Brett M. Baker, OIG, Memo Re Status of Recommendation Audit of Nrc'S Regulatory Oversight of RSOs
ML21123A0622021-05-0505 May 2021
Summary of Public Meeting with Holtec International to Discuss Upcoming Application for Certificate of Compliance No. 1032 for the HI-STORM Flood/Wind, Amendment No. 7
ML21028A6642021-04-28028 April 2021
Transmittal Memo to EDO from NMSS for ANPR Federal Register Notice - Categorical Exclusions from Environmental Review (Rin 3150-AK54; NRC-2018-0300)
ML21070A4132021-03-26026 March 2021
OEDO-20-00394 Status of Recommendations Audit of the Nrc'S Consultation Practices with Federally Recognized Native American Tribal Governments (OIG-18-A-10)
ML21042B9672021-02-18018 February 2021
OEDO-20-00297 - Update on Staff Response to the Office of Inspector General'S Audit of the U.S. Nuclear Regulatory Commission'S Emergency Preparedness Program (OIG-20-A-12)
ML21028A5022021-02-0101 February 2021
Summary of the January 5, 2021 Closed Meeting with Check-Cap Ltd. to Discuss the Applicability of 10 CFR 20.2003(b) for the Disposal of the C-Scan System to the Sanitary Sewer
ML20335A5712020-12-21021 December 2020
OIG-20-A-10-Status of Recommendations: Audit of Nrc'S Integrated Materials Performance Evaluation Program Dated December 21, 2020
ML20150B6152020-11-23023 November 2020
Memo to File: Environmental Assessment and Finding of No Significant Impact and NRC Financial Analysis for Exelon Generation Co., LLC Decommissioning Funding Plan Submitted in Accordance with 10 CFR 72.30(b) and (C) for Salem ISFSI
ML20213C5322020-11-23023 November 2020
Memo to File: Environmental Assessment and Finding of No Significant Impact and NRC Financial Analysis for Constellation Energy Decommissioning Funding Plan Submitted in Accordance with 10 CFR 72.30(b) and (C) for R.E. Ginna
ML20150A2862020-11-23023 November 2020
Memo to File: Environmental Assessment and Finding of No Significant Impact and NRC Financial Analysis for Exelon Generation Co., LLC Decommissioning Funding Plan Submitted in Accordance with 10 CFR 72.30(b) and (C) for LaSalle ISFSI
ML20246G6082020-09-30030 September 2020
OEDO-20-00129-Status of Recommendations: Audit of the U. S. Nuclear Regulatory Commission'S Consultation Practices with Federally Recognized Native American Tribal Governments (OIG-18-A-10)
ML20188A1732020-09-0303 September 2020
Results of Implementation Plan to Identify Depleted Uranium on Military Ranges and Determine Its Licensing Status
ML20240A2152020-09-0202 September 2020
OEDO-20-00160 - OIG-19-A-11 Update on Staff Response to the Office of the Inspector General'S Audit of U.S. Nuclear Regulatory Commission'S Training Selection Process for Agreement State Personnel
ML20174A5552020-07-28028 July 2020
Draft SER
ML20174A5542020-07-28028 July 2020
Draft Technical Specifications Appendix B for Magnastor Amendment 9
ML20174A5532020-07-28028 July 2020
Draft Technical Specifications Appendix a for Magnastor Amendment 9
ML20162A0042020-07-14014 July 2020
Request for Comments on Management Directive and Handbook 5.8, Proposed Section 274b. Agreements with States
ML20140A0062020-06-0303 June 2020
Summary of Meeting with Exubrion Therapeutic'S to Discuss Staff'S Request for Additional Information
ML20143A2812020-06-0101 June 2020
Inspection Guidance During Transition from COVID-19 Mandatory Telework for the Nuclear Material and Waste Safety Programs
ML20099A3812020-04-22022 April 2020
OIG-19-A-11 Update on Staff Response to the Office of the Inspector General'S Audit of U.S. Nuclear Regulatory Commission'S Training Selection Process for Agreement State Personnel
ML20111A0152020-04-17017 April 2020
Memorandum-COVID19 Resident Inspection Coverage
ML20066H8862020-04-15015 April 2020
Annual Report on Agreement States and U.S. Nuclear Regulatory Commissions Radioactive Materials Programs for Calendar Year 2019
ML20098D6382020-04-10010 April 2020
Enclosure 1- Template for Temporary Exemptions for Medical Licensees Due to the Covid-19 Pandemic
ML20063M5052020-04-0808 April 2020
Transmittal Memo Certificate of Compliance 1032, Amendment 5
ML20055E9152020-04-0303 April 2020
OEDO-19-00436-Status of Recommendations: Audit of the U. S. Nuclear Regulatory Commission'S Consultation Practices with Federally Recognized Indian Tribes
ML20022A3132020-01-24024 January 2020
Memo to Regions - Notification of Issuance of Xcision Gammapod Licensing Guidance
ML19319A9932020-01-0808 January 2020
Oedo Transmittal Memo for Rroar Initiative 2nd FRN
ML19351E1442019-12-0404 December 2019
Rmsc Slides (Final)
ML19290H6072019-11-26026 November 2019
Transmittal Memo - User Need Memo for CoC 1042 Eos A1
ML19319A4652019-11-15015 November 2019
Summary of Nov 6, 2019, Pre-Submittal Public Meeting with Exubrion Therapeutics
ML19325C0632019-11-14014 November 2019
Regulatory History for CoC No. 1008, Amendment No. 3
ML19291D2752019-10-31031 October 2019
Dfm November 2019 Update for Oig Audit
ML19298A0842019-10-28028 October 2019
Solicitation of Topics for the Organization of Agreement States Annual Meeting in Philadelphia
ML19239A0982019-10-18018 October 2019
Memorandum from C. Einberg to D. Metter NRC Response to July 24, 2019 Teleconference Meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI)
ML19274C6222019-10-18018 October 2019
Memorandum from C. Einberg to D. Metter NRC Response to September 10-11, 2019 Meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI)
2023-07-03
[Table view]Some use of "" in your query was not closed by a matching "". |
Text
Date, 2020
[Licensee POC and Address]
SUBJECT:
TEMPORARY EXEMPTION FROM U.S. NUCLEAR REGULATORY COMMISSION REGULATION, TITLE 10 CODE OF FEDERAL REGULATIONS (10 CFR) [LIST SECTION(S)].
Dear [Licensee POC]:
By letter dated [Date of Letter] (Agencywide Documents Access and Management System
[ADAMS] Accession No. [Accession Number], in accordance with Title 10 of the Code of Federal Regulations (10 CFR) 30.11(a), [licensee name], a medical use licensee, requested an exemption from the requirements of 10 CFR [list specific regulation(s)].
In its request, [the licensee] stated that due to [state the condition (i.e. medical facility protocol to limit staff, staff shortage, travel restrictions, potential for staff in isolation, etc.)] caused by the COVID-19 pandemic, these regulations cannot be safely met without increasing the possibility of exposing licensees employees, contractors, patients, or members of the general public to the COVID-19 virus. [The licensee] proposed that, if exempted from these requirements of 10 CFR [list specific regulation(s)], it would [provide any conditions the licensee stated they will continue doing while the exemption is in place.].
The exemption provision in 10 CFR 30.11(a) states:
The Commission may, upon application of any interested person or upon its own initiative, grant exemptions from the requirements of the regulations in this part and parts 31 through 36 and 39 of this chapter as it determines are authorized by law and will not endanger life or property or the common defense and security and are otherwise in the public interest.
The U.S. Nuclear Regulatory Commission (NRC) staff reviewed the request in accordance with 10 CFR 30.11(a) and finds that the criteria contained therein are met. The regulation[s] from which [the licensee] is requesting exemption [is/are] [Input description of exemption requested from spreadsheet. Note to reviewer - may make bulleted list if there are several requests]
The regulation in 10 CFR 30.11(a) authorizes granting of exemptions specific to Part [list appropriate part, i.e. 30 or 35]. The NRC staff has determined that the granting of the requested exemption will not result in a violation of the Atomic Energy Act of 1954, as amended, or the Commissions regulations. The NRC staff, therefore, finds that the granting of the requested exemption is authorized by law. [Input appropriate safety basis/bases from spreadsheet. Note to reviewer - may make bulleted list if there are several requests]
Based on the above findings, the NRC grants the following exemption for the specified period of time:
[Licensee POC] 2
[Input appropriate exemptions from spreadsheet. Note to reviewer - may make bulleted list if there are several requests]
[Include this following paragraph if the licensee requests additional exemptions currently not listed on the spreadsheet and more time is needed to review them.] The request for exemption from [list specific exemptions requested that couldnt be approved] is still under NRC review. The NRC will make a determination on that request at a later time.
An environmental assessment for this action is not required, because this action is categorically excluded under 10 CFR 51.22(c)(14)(iv). In accordance with 10 CFR 2.390 of the NRC's Rules of Practice, a copy of this letter and its enclosure will be available electronically for public inspection in the NRC Public Document Room or from the NRCs Agencywide Documents Access and Management System (ADAMS), accessible from the NRC Web site at https://www.nrc.gov/reading-rm/adams.html.
[Licensee POC] 3 If you have questions, please contact [license reviewer name] at [license reviewer email] or
[license review phone number].
Sincerely,
[Branch Chief], Chief
[Branch Name]
Division of Nuclear Materials Safety
[Region]
cc: [licensee specific]
[Please include Lisa Dimmick and Katie Tapp on distribution]
ML20100D405 *via e-mail OFFICE MSST MSST MSST OGC MSST NAME KTapp LDimmick CEinberg EHouseman* MLayton DATE 4/6/2020 4/6/2020 4/6/2020 4/8/2020 4/10/2020